Avi Reichenberg results 1
· Newest (Page 1/1, per page 25)
Author: Avi Reichenberg ×Clear All Filters
Search Results
Rationale Schizophrenia is associated with impairments in cognitive functioning yet there are no approved drugs to treat these deficits. Objectives Based on animal models, we investigated the potential for roflumilast, a selective inhibitor of phosphodiesterase type 4 (PDE4), to improve cognition, which may act by increasing intracellular cyclic adenosine monophosphate in brain regions underlying cognitive deficits in schizoph...
Previous1Next